Nisoldipine

CHEMBL1726 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

388.4 g/mol

LogP

3.3

Phase

4

A calcium channel blocker that relaxes the walls of blood vessels, reducing the heart's workload and lowering blood pressure.

Moleküler Ağırlık

388,4000 g/mol

LogP

3,30

TPSA

110,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Hypertension

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]

InChI

InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3

Molecular Formula

C20H24N2O6

HBD / HBA

1 / 7

Döndürülebilir Bağlar

7

Ağır Atomlar

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A calcium channel blocker that relaxes the walls of blood vessels, reducing the heart's workload and lowering blood pressure.

Yes, Nisoldipine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1726. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 4499. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Nisoldipine PillFYI'da

Yapı

Hızlı Veriler

Formül: C20H24N2O6
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.